Xortx announces participation at upcoming investor conferences

Calgary, alberta, nov. 03, 2022 (globe newswire) -- xortx therapeutics inc. ("xortx" or the “company”) (nasdaq: xrtx | tsxv: xrtx | frankfurt: anu), a late stage clinical pharmaceutical company focused on developing innovative therapies to treat progressive kidney disease, announces that dr. allen davidoff, president and ceo, is scheduled to participate in the following upcoming investor conferences:
XRTX Ratings Summary
XRTX Quant Ranking